Equal Opportunity, Unequal Participation: Investigating Sex Disparities In Clinical Trials
Caitlin Bozic,Eline S. de Klerk,Jennifer S. Breel,David M.P. van Meenen,Henning Hermanns,Olaf Kroon,Thomas A.E.M. Schokker,Marcus J. Schultz,Susanne Eberl
DOI: https://doi.org/10.1053/j.jvca.2024.09.125
IF: 2.894
2024-10-27
Journal of Cardiothoracic and Vascular Anesthesia
Abstract:Objective There is a well-documented sex disparity in clinical research worldwide. Historically, most studies were conducted predominantly on male participants. This raises concerns about the generalisability and extrapolability of the findings to female patients, who exhibit different physiological and pharmacological responses.The present study aimed to investigate whether participation willingness in prospective clinical trials, having no sex-specific restrictions on inclusion, was disparate for both sexes. Design and method This observational retrospective study utilised prospectively collected screening logs of clinical trials conducted in the Department of Anaesthesiology, Amsterdam UMC, over a 5-year period from 1 January 2019 to 31 December 2023. The Institutional Review Board of the Amsterdam UMC, situated at AMC, verified on 15 March 2023 that this study did not fall within the scope of the Medical Research involving Human Subjects Act (W23_111#23.136).The study population included adult patients of both sexes who were approached for participation in prospective interventional and observational clinical trials. Importantly, only clinical trials were included where both sexes had equal opportunity to participate, with no other sex-specific restrictions. To ensure data integrity, any patients who were approached for multiple trials were included only once, to avoid double-counting of individuals in the final analysis. Results and conclusions The preliminary data analysis included a total of 5 145 approached patients, of whom 3 995 (78%) were willing to participate in a study and 1 150 (22%) refused study participation. The study population had a median age of 62 years with a range from 18 to 96 years.Of the 5 145 patients approached, 2 509 (49%) were male, and 2 636 (51%) were female.However, when examining participation rates by sex, 2 018 (80%) of the males approached were willing to take part in a study, while only 1 977 (75%) of the females approached were inclined to do so. The difference in participation rates between males and females was statistically significant (p<.001).This study showed that when no sex-specific restrictions are placed on participation, the sexes were approached almost equally. However, when investigating effective participation rates by sex, a statistically significant difference is seen, where males participate more often, compared to females.It is important to understand the underlying factors that contribute to this observed sex disparity.Researchers should strive to ensure that the representation of males and females in clinical trials is proportional to the prevalence of the disease or condition being studied, in order to enhance the applicability of the research findings to the diverse patient population.
cardiac & cardiovascular systems,peripheral vascular disease,respiratory system,anesthesiology